"Gral Medical este o firma privata cu capital integral romanesc din topul celor mai mari companii din domeniul serviciilor medicale. Sub sloganul “Suferinte Vechi, Tratamente Noi”, Gral Medical a reusit sa implementeze servicii noi si eficiente pentru a veni in intampinarea pacientilor cu o alternativa la sistemul de sanatate existent. Astfel, in scurt timp, Gral Medical a devenit cea mai dinamica companie de servicii medicale din Romania, reusind sa construiasca o retea de 76 centre medicale in 9 judete din tara."

During the past decade, GRAL Medical SRL conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "GRAL Medical SRL" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "CanariaBio Inc." with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Ipsen" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "GRAL Medical SRL" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Gynecologic Oncology Group" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "GRAL Medical SRL" are "Abiraterone Acetate" (1 trials), "Androgens" (1 trials), "Antineoplastic Agents" (1 trials), "Antineoplastic Agents, Hormonal" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "GRAL Medical SRL" in a lesser frequency.

Most popular intervention types in "GRAL Medical SRL" are "Drug" (8 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "Placebo" (3 trials), "Abemaciclib" (2 trials), "Cisplatin" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "GRAL Medical SRL" are 5 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "GRAL Medical SRL". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in GRAL Medical SRL, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in GRAL Medical SRL, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".